IONIS PARTNER GSK ANNOUNCES POSITIVE TOPLINE RESULTS FROM B-WELL 1 AND B-WELL 2 PHASE 3 STUDIES FOR BEPIROVIRSEN, A POTENTIAL FIRST-IN-CLASS MEDICINE FOR CHRONIC HEPATITIS B

Reuters · 4d ago

Please log in to view news